Market News AIOpen the app

Eli Lilly's stock reached a new high as the CEO said more middle-income families want weight-loss drugs.

ResultsRead the original at Benzinga
Good for LLY

Lilly said broader middle-income interest and Medicare coverage helped improve its forecast by about $10 billion. Sales grew 39%, though demand is hard to predict, so the reported growth and room to reach more patients point to stronger prospects.

LLY · Eli Lilly and Co.

AI read · Good for LLY

The AI's read

More middle-income buyers could widen Lilly’s customer base for its weight-loss medicines. The company said this demand and Medicare coverage helped improve its forecast, and its medicines already bring in substantial sales. Demand remains hard to predict, but the reported growth and room to reach more patients support a positive reading.

Get alerts for LLY

Follow Eli Lilly and Co. (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LLY
Free on the App Store and Google Play, or on the web.